{
  "id": 9120268,
  "title": "Clearlake and Charlesbank to inject $175m into distressed Symplr",
  "url": "https://urgent.news/2026/09/22/clearlake-and-charlesbank-to-inject-175m-into-distressed-symplr",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-22T09:34:29.000Z",
  "source": {
    "name": "Private Equity Wire",
    "slug": "private-equity-wire",
    "url": "https://www.privateequitywire.co.uk/clearlake-and-charlesbank-to-inject-175m-into-distressed-symplr/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Private equity firms Clearlake Capital Group and Charlesbank Capital Partners have agreed to provide around $175m of preferred equity to healthcare software provider Symplr as part of a restructuring designed to shore up the company's finances and push out debt maturities, according to a report by Bloomberg.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}